Hay recursos disponibles en español. Explorar los recursos aquí »
For US 
Residents 
Only
Visit Health Care Professional Website
Patient Information (English | Español)
  Indication
Important Safety Information
Prescribing Information
ONCE-DAILY MEDICINE

Taking 
LIVMARLI

The only ileal bile acid transporter (IBAT) inhibitor available as a tablet or a liquid (oral solution) medicine.

Smiling star sticker

ONCE-DAILY DOSING

When and how is LIVMARLI taken?

LIVMARLI is the only IBAT inhibitor available as a liquid medicine or a tablet. Both LIVMARLI tablets and liquid medicine are taken by mouth.

LIVMARLI liquid medicine

Take directly from the required measuring device delivered with your medicine.

LIVMARLI bottle and measuring device not actual size.

LIVMARLI tablets

Tablets come in 4 fixed doses:

Tablets and dime not actual size. Dime shown for scale.

One Dose,
Once Per Day

Both LIVMARLI oral solution and tablets should be taken once daily at the dosage prescribed. Take LIVMARLI 30 minutes before a meal in the morning

Dosing information:

  • Your doctor will prescribe the right dose of LIVMARLI for you
  • Dosing for LIVMARLI is based on weight. Never change the amount of LIVMARLI without first talking to your doctor

What happens if a dose is missed?

  • If you miss a dose within 12 hours of the time you normally take it, take LIVMARLI as soon as possible. Then take your next dose at the usual time
  • If a dose is missed by more than 12 hours, skip the dose and continue your original dosing schedule the next day

For more information, please read the Instructions for Use.

Download the English Version Descargar la Versión en Español

BE A KNOW-IT-ALL

Be a Know-It-All

What should you know when taking LIVMARLI?

When starting a medication, it’s important to talk to your doctor or your child's doctor so they can help you better understand what to expect.

Doctor discussion

Here are a few things to discuss with your doctor when starting LIVMARLI:

Don’t stop or change the dose on your own without talking to your doctor first.

How LIVMARLI May Help

Download the LIVMARLI Brochure Descarger el Folleto de LIVMARLI
MAP logo

Lower Costs Within Reach

Mirum Access Plus works closely with your doctor and insurance plan to help facilitate coverage for LIVMARLI.

Learn How to Enroll
Binoculars

Rise Above Cholestatic Pruritus (Itch)

Learn about the results of LIVMARLI in patients with cholestatic pruritus in Alagille syndrome.

See LIVMARLI in Action

Indication

LIVMARLI is a prescription medicine used to treat cholestatic pruritus (itch) in patients who are 3 months of age and older with Alagille syndrome.

It is not known if LIVMARLI is safe and effective in children with Alagille syndrome who are under 3 months of age. It is not known if LIVMARLI is safe and effective in adults who are 65 years of age and older.

Important Safety Information

What are the possible side effects 
of LIVMARLI?

LIVMARLI can cause serious side effects, including:

  • Liver injury. Changes in certain liver tests are common in patients but may worsen during treatment with LIVMARLI. These changes may be a sign of liver injury and can be serious. Your health care provider should do blood tests and physical exams before starting and during treatment to check your liver function. Tell your health care provider right away if you get any signs or symptoms of liver problems, including:
    • nausea or vomiting
    • your skin or the white part of your eye turns yellow
    • dark or brown urine
    • pain on the right side of your stomach (abdomen)
    • fullness, bloating, or fluid in your stomach area (ascites)
    • loss of appetite
    • bleeding or bruising more easily than normal, including vomiting blood
  • Stomach and intestinal (gastrointestinal) problems. LIVMARLI can cause stomach and intestinal problems, including diarrhea and stomach pain during treatment. Diarrhea can also cause the loss of too much body fluid (severe dehydration). Your health care provider may advise you to monitor for new or worsening stomach problems, including stomach pain, diarrhea, blood in your stool, or vomiting. Tell your health care provider right away if you have any new or worsening signs or symptoms of stomach and intestinal problems, including:
    • diarrhea
    • more frequent bowel movements than usual
    • stools that are black, tarry, or sticky, or have blood or mucous
    • severe stomach-area pain or tenderness
    • vomiting
    • urinating less often than usual
    • dizziness
    • headache
  • A condition called Fat-Soluble Vitamin (FSV) Deficiency caused by low levels of certain vitamins (vitamin A, D, E, and K) stored in body fat. FSV deficiency is common in patients with Alagille syndrome but may worsen during treatment. Your health care provider should do blood tests before starting and during treatment, and may monitor for bone fractures and bleeding, which are common side effects.

Tell your health care provider about all medicines that you take, as LIVMARLI may interact with other medicines. If you take a medicine that lowers cholesterol by binding bile acids, such as cholestyramine, colesevelam, or colestipol, take LIVMARLI at least 4 hours before or 4 hours after you take that medicine.

Your health care provider may change your dose, or temporarily or permanently stop treatment if you have certain side effects.

LIVMARLI is available in oral solution and tablet formulations. LIVMARLI is taken by mouth, 1 time each day, 30 minutes before a meal in the morning. For the oral solution, be sure to use the provided oral dosing dispenser to accurately measure the dose of medicine.

These are not all of the possible side effects of LIVMARLI. For more information, ask your health care provider or pharmacist. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

Please see full Prescribing Information, including Patient Information and Instructions for Use, for LIVMARLI.

expand btn collapse btn

Indication

LIVMARLI is a prescription medicine used to treat cholestatic pruritus (itch) in patients who are 3 months of age and older with Alagille syndrome.

It is not known if LIVMARLI is safe and effective in children with Alagille syndrome who are under 3 months of age. It is not known if LIVMARLI is safe and effective in adults who are 65 years of age and older.

Important Safety Information

What are the possible side effects 
of LIVMARLI?

LIVMARLI can cause serious side effects, including:

  • Liver injury. Changes in certain liver tests are common in patients but may worsen during treatment with LIVMARLI. These changes may be a sign of liver injury and can be serious. Your health care provider should do blood tests and physical exams before starting and during treatment to check your liver function. Tell your health care provider right away if you get any signs or symptoms of liver problems, including:
    • nausea or vomiting
    • your skin or the white part of your eye turns yellow
    • dark or brown urine
    • pain on the right side of your stomach (abdomen)
    • fullness, bloating, or fluid in your stomach area (ascites)
    • loss of appetite
    • bleeding or bruising more easily than normal, including vomiting blood
  • Stomach and intestinal (gastrointestinal) problems. LIVMARLI can cause stomach and intestinal problems, including diarrhea and stomach pain during treatment. Diarrhea can also cause the loss of too much body fluid (severe dehydration). Your health care provider may advise you to monitor for new or worsening stomach problems, including stomach pain, diarrhea, blood in your stool, or vomiting. Tell your health care provider right away if you have any new or worsening signs or symptoms of stomach and intestinal problems, including:
    • diarrhea
    • more frequent bowel movements than usual
    • stools that are black, tarry, or sticky, or have blood or mucous
    • severe stomach-area pain or tenderness
    • vomiting
    • urinating less often than usual
    • dizziness
    • headache
  • A condition called Fat-Soluble Vitamin (FSV) Deficiency caused by low levels of certain vitamins (vitamin A, D, E, and K) stored in body fat. FSV deficiency is common in patients with Alagille syndrome but may worsen during treatment. Your health care provider should do blood tests before starting and during treatment, and may monitor for bone fractures and bleeding, which are common side effects.

Tell your health care provider about all medicines that you take, as LIVMARLI may interact with other medicines. If you take a medicine that lowers cholesterol by binding bile acids, such as cholestyramine, colesevelam, or colestipol, take LIVMARLI at least 4 hours before or 4 hours after you take that medicine.

Your health care provider may change your dose, or temporarily or permanently stop treatment if you have certain side effects.

LIVMARLI is available in oral solution and tablet formulations. LIVMARLI is taken by mouth, 1 time each day, 30 minutes before a meal in the morning. For the oral solution, be sure to use the provided oral dosing dispenser to accurately measure the dose of medicine.

These are not all of the possible side effects of LIVMARLI. For more information, ask your health care provider or pharmacist. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

Please see full Prescribing Information, including Patient Information and Instructions for Use, for LIVMARLI.